December 18, 2017 / 2:50 PM / 6 months ago

BRIEF-Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Approval Of Yervoy (ipilimumab)

Dec 18 (Reuters) - Bristol-Myers Squibb Co:

* BRISTOL-MYERS SQUIBB RECEIVES POSITIVE CHMP OPINION RECOMMENDING APPROVAL OF YERVOY (IPILIMUMAB) FOR THE TREATMENT OF PEDIATRIC PATIENTS 12 YEARS AND OLDER WITH UNRESECTABLE OR METASTATIC MELANOMA

* BRISTOL-MYERS SQUIBB CO - APPROVAL OF YERVOY FOR PEDIATRIC PATIENTS 12 YEARS OF AGE AND OLDER WHO HAVE UNRESECTABLE OR METASTATIC MELANOMA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below